PASITHEA THERAPEUTICS CORP.
Income Statement
| Line Item | FY2022 | FY2021 |
|---|---|---|
| Revenue | $486.6K | $15.1K |
| Cost of Revenue | $113.2K | $17.3K |
| Gross Profit | $373.4K | $-2.2K |
| Gross Margin | 76.7% | -14.7% |
| Operating Expenses | ||
| Research & Development | $2.7M | — |
| SG&A Expense | $9.9M | $4.5M |
| Operating Income | $-12.6M | $-4.5M |
| Operating Margin | -2,587.3% | -29,925.7% |
| Interest Expense | $102 | $508 |
| Pretax Income | $-11.7M | $-2.2M |
| Income Tax Expense | — | — |
| Net Income | $-13.9M | $-2.2M |
| Net Margin | -2,864.3% | -14,430.5% |
| EPS (Basic) | $-0.29 | $-0.04 |
| EPS (Diluted) | $-0.29 | $-0.04 |
| Shares Outstanding (Basic) | 7.6M | 62.4M |
| Shares Outstanding (Diluted) | 7.6M | 62.4M |
| Dividends Per Share | — | — |